The present technology is generally related to systems and methods for planning a patient-specific spinal correction surgery and/or conducting a surgery.
Spinal disorders such as adolescent idiopathic scoliosis, degenerative disc disease, disc herniation, osteoporosis, spondylolisthesis, stenosis, scoliosis, kyphosis and other curvature abnormalities, tumor, and fracture may result from factors including trauma, disease and degenerative conditions caused by injury and aging. Spinal disorders or deformities typically result in symptoms including pain, nerve damage, and partial or complete loss of mobility, at a minimum. In adolescence, spinal deformity may affect lung capacity and other bodily functions.
Spinal surgery may involve implantation of one or more spinal implants, such as a spinal rod, to correct the curvature of the spine of a patient and to prevent further deterioration. In adolescent idiopathic scoliosis, concaved and convex spinal rods of particular curvatures are used. These spinal rods, however, can deform based on in vivo impact forces. The spinal rod curvature can be a key factor in the treatment of a spinal deformity.
This disclosure describes an improvement over these prior art technologies.
The techniques of this disclosure generally relate to systems and methods for planning a patient-specific spinal correction that may include designing a patient-specific spinal implant based on a three-dimensional (3D) nature of a deformity, for example, to correct a patient-specific adolescent idiopathic scoliosis (AIS) deformity, such as by designing a rod contour that accounts for rod deformation and/or bending out to achieve a thoracic kyphosis goal for use in treating the deformity.
In one aspect, the present disclosure provides a method to plan a spinal correction surgery. The method includes, for example, measuring spinal parameters of a spine in a two-dimensional (2D) pre-operative spinal image including at least a pre-operative thoracic Cobb angle and a pre-operative thoracic kyphosis and transforming the 2D pre-operative spinal image to a three-dimensional (3D), pre-operative spinal image representation. The transforming may include performing segmentation of spine elements in the 2D pre-operative spinal image, and applying a mathematical formula based on the thoracic Cobb angle and the thoracic kyphosis to the spine elements. The method includes identifying a thoracic kyphosis goal having a post-operative thoracic kyphosis value to a selected set of the spine elements, transforming a gap of the spine elements representative of a difference between the pre-operative thoracic kyphosis in 3D pre-operative spinal image representation and the thoracic kyphosis goal to create a 3D post-operative spinal image representation, and determining a first rod design based on the 3D post-operative spinal image representation to achieve the post-operative thoracic kyphosis value in the selected set of spine elements.
In another aspect, the disclosure provides a system that includes, for example, at least one processor and a non-transitory and tangible computer readable storage medium having programming instructions stored thereon, which when executed cause the at least one processor to measure spinal parameters of a spine in a two-dimensional (2D) pre-operative spinal image including at least a pre-operative thoracic Cobb angle and a pre-operative thoracic kyphosis; and transform the 2D pre-operative spinal image to a three-dimensional (3D), pre-operative spinal image representation. The processor may, for example, transform the 2D image by: performing segmentation of spine elements in the 2D pre-operative spinal image; and applying a mathematical formula based on the thoracic Cobb angle and the thoracic kyphosis to the spine elements. The processor, for example, may also identify a thoracic kyphosis goal having a post-operative thoracic kyphosis value to a selected set of the spine elements, transform a gap of the spine elements representative of a difference between the pre-operative thoracic kyphosis in 3D pre-operative spinal image representation and the thoracic kyphosis goal to create a 3D post-operative spinal image representation, and determine a first rod design based on the 3D post-operative spinal image representation to achieve the post-operative thoracic kyphosis value in the selected set of spine elements.
In another aspect, the disclosure provides a method, for example, that includes planning a surgery to correct a spinal deformity and obtaining a rod formed of biocompatible material configured to approximate a first rod design. The method may include during surgery, bending the rod with a rod bending device to create the first rod design; and implanting the bent rod.
The details of one or more aspects of the disclosure are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the techniques described in this disclosure will be apparent from the description and drawings, and from the claims.
The embodiments described herein relate to systems and methods for planning a patient-specific spinal correction that may include designing a patient-specific spinal implant based on a three-dimensional (3D) nature of a deformity, for example, to correct a patient-specific adolescent idiopathic scoliosis (AIS) deformity, such as by designing a rod contour that accounts for rod deformation and/or bending out to achieve a thoracic kyphosis goal for use in treating the deformity.
In particular, some embodiments described herein are directed to the design and/or manufacture of patient-specific spinal rods. In some embodiments, the systems and methods described herein may be configured to design and/or produce a patient-specific spinal rod for use in a surgical procedure to correct a spinal deformity.
The planning system of the present disclosure may be understood more readily by reference to the following detailed description of the embodiments taken in connection with the accompanying drawing figures that form a part of this disclosure. It is to be understood that this application is not limited to the specific devices, methods, conditions or parameters described and/or shown herein, and that the terminology used herein is for the purpose of describing particular embodiments by way of example only and is not intended to be limiting. Also, in some embodiments, as used in the specification and including the appended claims, the singular forms “a,” “an,” and “the” include the plural, and reference to a particular numerical value includes at least that particular value, unless the context clearly dictates otherwise. Ranges may be expressed herein as from “about” or “approximately” one particular value and/or to “about” or “approximately” another particular value. When such a range is expressed, another embodiment includes from the one particular value and/or to the other particular value. Similarly, when values are expressed as approximations, by use of the antecedent “about,” it will be understood that the particular value forms another embodiment. It is also understood that all spatial references, such as, for example, horizontal, vertical, top, upper, lower, bottom, front, back, left and right, are for illustrative purposes only and can be varied within the scope of the disclosure. For example, the references “upper” and “lower” are relative and used only in the context to the other, and are not necessarily “superior” and “inferior”.
Further, as used in the specification and including the appended claims, “treating” or “treatment” of a disease or condition may refer to planning for and performing a procedure that may include administering one or more drugs to a patient (human or other mammal), employing implantable devices, and/or employing instruments that treat the disease, such as, for example, instruments used to implant bone constructs, pedicle screws, and spinal rods, for example.
Alleviation can occur prior to signs or symptoms of the disease or condition appearing, as well as after their appearance. Thus, treating or treatment includes preventing or prevention of and/or reducing the likelihood of a certain disease or undesirable condition (e.g., preventing or reducing the likelihood of the disease from occurring in a patient, who may be predisposed to the disease but has not yet been diagnosed as having it). In addition, treating or treatment does not require complete alleviation of signs or symptoms, does not require a cure, and specifically includes procedures that have only a marginal effect on the patient. Treatment can include inhibiting the disease, e.g., arresting its development, or relieving the disease, e.g., causing regression of the disease. For example, treatment can include reducing acute or chronic inflammation; alleviating pain and mitigating and inducing re-growth of new ligament, bone and other tissues; as an adjunct in surgery; and/or any repair procedure. Also, as used in the specification and including the appended claims, the term “tissue” includes soft tissue, ligaments, tendons, cartilage and/or bone unless specifically referred to otherwise.
The following disclosure includes a description of a computing system for generating a model of a three-dimensional (3D) nature of a patient-specific deformity, planning a correction of the patient-specific deformity and/or for designing a rod contour with a degree of bending out. The following disclosure includes a description of computer-implemented methods of employing the computing system in accordance with the principles of the present disclosure. Alternate embodiments are also disclosed. Reference is made in detail to the exemplary embodiments of the present disclosure, which are illustrated in the accompanying figures.
The designed implant rod may be fabricated from biologically acceptable materials suitable for medical applications, including computer aided metals, computer aided plastics, metals, synthetic polymers, ceramics and bone material and/or their composites. For example, the rod may be fabricated from materials such as stainless steel alloys, aluminum, commercially pure titanium, titanium alloys, Grade 5 titanium, superelastic titanium alloys, cobalt-chrome alloys, stainless steel alloys, superelastic metallic alloys (e.g., Nitinol, super elasto-plastic metals, such as GUM METAL® manufactured by Toyota Material Incorporated of Japan), ceramics and composites thereof such as calcium phosphate (e.g., SKELITE™ manufactured by Biologic, Inc.), thermoplastics such as polyaryletherketone (PAEK) including polyetheretherketone (PEEK), polyetherketoneketone (PEKK) and polyetherketone (PEK), carbon-PEEK composites, PEEK-BaSO4 polymeric rubbers, polyethylene terephthalate (PET), fabric, silicone, polyurethane, silicone-polyurethane copolymers, polymeric rubbers, polyolefin rubbers, hydrogels, semi-rigid and rigid materials, elastomers, rubbers, thermoplastic elastomers, thermoset elastomers, elastomeric composites, rigid polymers including polyphenylene, polyamide, polyimide, polyetherimide, polyethylene, epoxy, and tissue growth or differentiation factors, partially resorbable materials, such as, for example, composites of metals and calcium-based ceramics, composites of PEEK and calcium based ceramics, composites of PEEK with resorbable polymers, totally resorbable materials, such as, for example, calcium based ceramics such as calcium phosphate, tri-calcium phosphate (TCP), hydroxyapatite (HA)-TCP, calcium sulfate, or other resorbable polymers such as polyaetide, polyglycolide, polytyrosine carbonate, polycaroplaetohe and their combinations.
The rod may have material composites, including the above materials, to achieve various desired characteristics such as strength, rigidity, elasticity, compliance, biomechanical performance, durability and radiolucency or imaging preference. The rod may also be fabricated from a heterogeneous material such as a combination of two or more of the above-described materials. The rod may be monolithically formed.
This disclosure incorporates herein by reference in its entirety U.S. Ser. No. 17/130,492, entitled “SYSTEMS, METHODS, AND DEVICES FOR DEVELOPING PATIENT-SPECIFIC SPINAL IMPLANTS, TREATMENTS, OPERATIONS, AND/OR PROCEDURES.”
The method steps described herein may be performed in the order shown or a different order. One or more method steps may be performed contemporaneously. One or more method steps may be added or deleted.
The method 100 may include (at 102) receiving, by at least one processor 1105 (
The method 100 may include (at 104) determining, by at least one processor 1105, 2D spine measurements based on the 2D patient image. For example, the 2D measurements may include one or more of pre-op values, such as, sagittal Cobb (SCobb) angle, coronal Cobb (CCobb) angle, thoracic Cobb (TCobb) angle, lumbar Lordis (LL), pelvic incidence (PI), thoracic kyphosis (TK), sacaral slope (SS) and pelvic tilt (PT), for example. The 2D spine measurements are pre-operation (pre-op) measurements. The 2D spine measurements may include a sagittal vertical axis (SVA) pre-op value, for example. The image data may be analyzed using machine-learning algorithms 1123 to perform one or more spine measurements 1161 (
When performing 2D spine measurements based on the 2D patient image (at 104), the at least one processor 1105, may be configured to perform segmentation 1160 (
In some embodiments, the at least one processor 1105 when performing one or more steps, such as without limitation, segmentation of images, may be configured to utilize machine-learning algorithms 1123 (
In some embodiments, when determining pre-op spine measurements (at 104), the at least one processor 1105 may be configured to receive, access, and/or obtain one or more other pre-op radiographic parameters or values as well, such as Central Sacral Vertical Line (CSVL), C2TH1 Pelvic Angle)(CTPA,°), C2C7 SVA (mm) (Sagittal Vertical Axis), Cervical Lordosis, Lenke Classification, Proximal Junctional Kyphosis (PJK), sacral slope (SS), TH1 Slope)(TH1S,°) TH1 Tilt Angle and Direction, TH1O-L2 angle, TH12-S1 Lumbar Lordosis (LL), TH1-TH12, TH2-TH12, TH2-TH5, TH5-TH12 Thoracic Kyphosis, Thoracic (TH) Apex, Th Curves/Cobb angles, TH Curve Levels, (TH/L Lumbar Apex, TH/L Lumbar Curve, TH/L Lumbar Curve Direction of curve, TH/L Lumbar Curve Levels), TH1 Pelvic Angle (TPA), Anatomical Kyphosis, Anatomical Lordosis, Cobb Angles, Coordinates of all vertebra corners in the sagittal and/or coronal planes and the femoral heads, and any other pre-operative data like, Computerized tomography Performed, Tri-Radiate Cartilage, External Auditory Meadus, Pelvic Obliquity, Acetabular Index, and/or the like.
The method 100 may include (at 106) performing, by at least one processor 1105, a 3D transformation of the 2D spinal image representation to a 3D spinal image representation, such as for display on a display device.
When performing the 3D transformation (at 106), the at least one processor 1105 may be configured to apply a mathematical formula representative of a 3D transformation to the 2D spinal image representation and generate the 3D spinal image 606B representation, as will be described in more detail in relation to
18.1+(0.81*2D TK)−(0.54*2D TCobb angle) EQ1,
as described in “Predicting 3D Thoracic Kyphosis Using Traditional 2D Radiographic Measurements in Adolescent Idiopathic Scoliosis,” by Kevin Parvaresh, MD, Spine Deformity 5 (2017) 159-165, incorporated herein by reference in its entirety.
In certain embodiments, the method may include receiving, accessing, and/or obtaining one or more radiographic parameters, such as for example, pre-operative data such as TH4-TH12 Thoracic Kyphosis (TK), L1-S1 Lumbar Lordosis (LL), Sagittal Vertical Axis (SVA), Pelvic Tilt (PT), Pelvic Incidence (PI), Lordosis, and/or the like.
In some embodiments, a first set of input values for pre-operative and/or post-operative data may include one or more of the following: TH4-TH12 TK, L1-S1 LL, SVA, Lowermost Instrumented Vertebrae (LIV), Uppermost Instrumented Vertebrae (UIV), Pelvic Tilt, Age at the time of surgery, and/or Pelvic Incidence (PI). The at least one processor 1105 may be configured to perform the 2D-to-3D transformation 1162 using one or more machine-learning algorithms described herein.
The method may include (at 108), by at least one processor 1105, determining a thoracic kyphosis goal, and example is shown in
In some embodiments, when determining a thoracic kyphosis goal, at least one processor 1105, (at 108) may be configured to select one or more input parameters, for example, age, PI pre-op value, PT pre-op value, LL pre-op value, TK pre-op value, SVA pre-op value, lower instrumented level, upper instrumented level, LL post-op target value, surgeon, weight, shape of the pre-operative spline, pre-operative x-ray, or the like. In some embodiments, the at least one processor 1105 may be configured to standardize the range of input parameters and/or utilize a scaling methodology for displaying on a display device using one or more GUIs. The at least one processor 1105 may be configured to allow a vertebrae range to be selected either by input fields or by selecting (marking) first and second locations on the image representative of the selected set of vertebrae to achieve the thoracic kyphosis goal.
The thoracic kyphosis goal may be determined using machine-learning algorithms 1123, by at least one processor 1105. In some embodiments, the method 100, when determining a thoracic kyphosis goal (at 108), may include generating, by the at least one processor 1105, a predictive model for determining post-operative parameters, such as for example thoracic kyphosis and/or pelvic tilt, using a thoracic kyphosis goal module 1166 and datasets 1127, for example. The generating may include accessing a dataset 1127 (
The method may include (at 110), by at least one processor 1105, performing a gap 3D transform to represent the patient's 3D model of the spine corrected to the thoracic kyphosis goal. In some embodiments, the total mean thoracic kyphosis may be 47° for adults, for example, as described in “Compensatory Spinopelvic Balance Over the Hip Axis and Better Reliability in Measuring Lordosis to the Pelvic Radius on Standing Lateral Radiographs of Adult Volunteers and Patients,” Roger P. Jackson MD, et al., SPINE Vol. 23, No. 16, pp. 1750-1767, copyright 1998, Lippincott Williams & Wilkins, incorporated herein by reference in its entirety. By way of non-limiting example, the adolescent patient may be corrected to conform to an adult total thoracic kyphosis. The total mean thoracic kyphosis in degrees may be calculated based on the total kyphosis from TH1-TH12 based on the Cobb method.
The gap 3D transformation may be determined using machine-learning algorithms 1123, by at least one processor 1105, using a predicted model of the gap transformation 1163 and related datasets 1127. The datasets 1127 may be trained based on radiological analysis of patients having a similar deformity. The dataset 1127 may include training data to train the machine-learning algorithms.
The 3D transforming, by the at least one processor 1105, may include determining one or more 3D pre-operative spinopelvic parameters to obtain one or more pre-operative spinopelvic parameters in a frequency domain. The transforming may include applying a Fourier transformation to the determined one or more pre-operative spinopelvic parameters, filtering, using at least one processor 1105, the one or more pre-operative spinopelvic parameters in the frequency domain. The filtering may include filtering out one or more of the one or more pre-operative spinopelvic parameters in the frequency domain including a frequency level above a predetermined threshold. The transforming may include applying, using at least one processor 1105, one or more predictive models to generate a predicted surgical outcome in the frequency domain based at least in part on the filtered one or more pre-operative spinopelvic parameters in the frequency domain and the one or more pre-operative non-imaging data of the subject. The one or more predictive models may include one or more of a generative adversarial network (GAN) algorithm, convolutional neural network (CNN) algorithm, or recurrent neural network (RNN) algorithm. The transforming, using at least one processor 1105, may transform the generated predicted surgical outcome in the frequency domain to obtain a generated predictive surgical outcome in a spatial domain. The transforming of the generated predicted surgical outcome in the frequency domain may include applying an inverse Fourier transformation to the generated predicted surgical outcome in the frequency domain, and generating a patient-specific spinal treatment based at least in part on the generated predictive surgical outcome in the spatial domain. The generated patient-specific spinal treatment may include one or more patient-specific spinal surgical procedures.
The method 100 may include (at 112) determining or generating, by at least one processor 1105, spinal surgical strategies including one or more surgical data parameters, such as Instrumentation Material, Instrumentation Size, Instrumentation Type, Minimal Invasive Surgery (MIS) options, Number of instrumented Levels, Osteotomies Performed, Rod Bending shapes and/or Angles, Rod Cutting Parameters, Uppermost Instrumented Parameters, Upper Instrumented Vertebrae (UIV), Lower Instrumented Vertebrae (LIV), Surgeon, surgical techniques (in some embodiments, using one or more machine learning algorithms to analyze surgeon's surgical techniques to be able to simulate the surgery and the rod that will match surgeon's expectations), radiography as an image, scanner, MRI (image or set of images), and/or the like. The machine-learning algorithms 1123, for surgical strategies 1165 may employ supervised machine learning, semi-supervised machine learning, unsupervised machine learning, deep learning and/or reinforcement machine learning. Each of these listed types of machine-learning algorithms is well known in the art.
In various embodiments computer-aided design programming applications may be used to draw or trace a rod geometric design. The particular type of drawing software utilized is not dependent on the system as the system may, irrespective of the particular platform or software utilized, generate manufacture or machine drawings to manufacture a rod.
The method 100 may include (at 112) creating, by at least one processor 1105, a first rod geometry (at 114) and/or a second rod geometry (at 116), as will be described in more detail in relation to
The method 100 may include (at 116) creating a second rod geometry by performing difference bending of a patient-specific second rod that may be configured to be a compliment to the first rod for the treatment to correct the spine in a patient.
The method 114 may include (at 304), by at least one processor 1105, approximating a bend out in a first rod geometry, for example. An example process to determine a bend out of a concave rod is described in “Postoperative Changes in Spinal Rod Contour in Adolescent Idiopathic Scoliosis, An in Vivo Deformation Study,” by Krishna R. Cidambi, M D et al., SPINE Vol. 37, No. 18, pp. 1566-1572, copyright 2012, Lippincott Williams & Wilkins, incorporated herein by reference in its entirety. For example, in some embodiments, a overbending or overcontouring by approximately 20° for a concaved rod may provide a minimal amount of loss in sagittal alignment. The bend out to effectuate an increase kyphosis may be determined using machine-learning algorithms 1123 for rod designing 1164 based on trained data between pre-operative and post-operative rod contours, and specifically based on the material used to manufacture the rod. Material properties of biocompatible materials, described above, may each have a deformation signature response to the in vivo deforming forces. The deformation signature response may be a function of the rod length, the rod diameter, the rod material, by way of non-limiting example. The trained data (i.e., datasets 1127) may be determined based on 2D image data, for example, between pre-operative and post-operative rod contours of rods made of varying materials. The process to approximate the bend out of a patient-specific first rod, will be described in more detail in
The planning of the bend out may also require knowledge of surgery strategies, as determined, for example, by algorithms for surgical strategies 1165 and datasets 1127, based on preferences of the surgeon, actual surgical cases, surgical case simulation or robotic surgery system. For example, bend out may be based on in situ rod bending techniques and/or bending devices. The bend out may be based on instrumentation or processes for rod implantation.
The bending of the rod geometry may be a function of the maximal deflection of the rod with greatest deformation due to bending and an angle of intersection of tangents to the rod end points. The rod geometry generates a first approximation for bending the rod geometry for treatment of the deformity. The second approximation for bending the rod geometry may be an overbending for a concave rod or underbending for a convex rod. The second approximation may be configured to compensate for the deformation signature response of the rod to the in vivo deforming forces.
The method 114 may include (at 306), by at least one processor 1105, performing a difference bending procedure for designing or creating the second rod geometry (at 116).
The method steps 402, 404, 406 and 408, for example, may be used for developing a deformation signature response of the implanted rod, as certain materials may have a different bending strengths and performance.
The surgery planning system described herein may be part of a navigation processor system 1178 (
Before surgery, at least one rod made of biocompatible material may be made to the specification that approximates the at least one rod geometry. The final bent rods may be individually bent by the surgeon using a bending device during surgery. The rods may be bent so that the rods conform to the final rod geometries. Thereafter, using the navigation processor system 1178, the surgeon may proceed to implant each rod according to the planned surgery.
A bus 1110 serves as the main information highway interconnecting the other illustrated components of the hardware. Processor(s) 1105 may be the central processing unit (CPU) of the computing system, performing machine-learning algorithms, calculations and logic operations as may be required to execute a program. CPU 1105, alone or in conjunction with one or more of the other elements disclosed in
Program instructions 1122, software or interactive modules for providing the interface and performing any querying and analysis. The analysis may include interfacing machine-learning algorithms 1123 be stored in the computer-readable storage media (e.g., memory device 1120). The machine-learning algorithms 1123 includes algorithms for image segmentation 1160, spinal measurements 1161, 2D-to-3D transformation 1163, gap transformation 1163, rod designing 1164, thoracic kyphosis goal module 1166 and surgical strategies 1165 associated with one or more datasets 1127 stored in the computer-readable storage media (e.g., memory device 1120). Optionally, the program instructions may be stored on a tangible, non-transitory computer-readable medium such as a compact disk, a digital disk, flash memory, a memory card, a universal serial bus (USB) drive, an optical disc storage medium and/or other recording medium.
An optional display interface 1130 may permit information from the bus 1110 to be displayed on the display device 1135, such as display device 602, 702, 802, 902 or 1002, in audio, visual, graphic or alphanumeric format. Electronic communication with external devices may occur using various communication ports 1140. A communication port 1140 may be attached to a communications network, such as the Internet or an intranet. In various embodiments, electronic communications with external devices may occur via one or more short range communication protocols. The communication port or devices 1140 may include communication devices for wired or wireless communications and may communicate with a remote server 1190. By way of non-limiting example, the computing system 1100 may receive 2D images 1195 of the patient from a remote server 1190 via communication devices 1140.
The hardware may also include a user interface 1145 that allows for receipt of data from input devices, such as a keyboard or other input device 1150 such as a mouse, a joystick, a touch screen, a remote control, a pointing device, a video input device and/or an audio input device. The GUIs 1170, described herein, may be displayed using a browser application being executed by an electronic device, computing system 1100 and/or served by a remote server (1190). For example, hypertext markup language (HTML) (i.e., programming instructions) may be used for designing the GUI with HTML tags to the images of the patient and other information stored in or served from memory of the server. The GUIs 1170 may include the GUIs 600A, 600B, 700A, 700B, 800, 900 and 1000, for example.
In this document, “electronic communication” refers to the transmission of data via one or more signals between two or more electronic devices, whether through a wired or wireless network, and whether directly or indirectly via one or more intermediary devices. Devices are “communicatively connected” if the devices are able to send and/or receive data via electronic communication.
It should be understood that various aspects disclosed herein may be combined in different combinations than the combinations specifically presented in the description and accompanying drawings. It should also be understood that, depending on the example, certain acts or events of any of the processes or methods described herein may be performed in a different sequence, may be added, merged, or left out altogether (e.g., all described acts or events may not be necessary to carry out the techniques). In addition, while certain aspects of this disclosure are described as being performed by a single module or unit for purposes of clarity, it should be understood that the techniques of this disclosure may be performed by a combination of units or modules associated with, for example, a medical device or system.
In one or more examples, the described techniques and methods may be implemented in hardware, software, firmware, or any combination thereof. If implemented in software, the functions may be stored as one or more instructions or code on a computer-readable medium and executed by a hardware-based processing unit. Computer-readable media may include non-transitory computer-readable media, which corresponds to a tangible medium such as data storage media (e.g., RAM, ROM, EEPROM, flash memory, or any other medium that may be used to store desired program code in the form of instructions or data structures and that may be accessed by a computer).
Instructions may be executed by one or more processors 1105, such as one or more digital signal processors (DSPs), general purpose microprocessors, application specific integrated circuits (ASICs), field programmable logic arrays (FPGAs), or other equivalent integrated or discrete logic circuitry. Accordingly, the term “processor” as used herein may refer to any of the foregoing structure or any other physical structure suitable for implementation of the described techniques. Also, the techniques could be fully implemented in one or more circuits or logic elements.
Number | Name | Date | Kind |
---|---|---|---|
4382438 | Jacobs | May 1983 | A |
5006984 | Steele | Apr 1991 | A |
5163440 | DeLuca et al. | Nov 1992 | A |
5209752 | Ashman et al. | May 1993 | A |
5224035 | Yamashita et al. | Jun 1993 | A |
5251127 | Raab | Oct 1993 | A |
5291901 | Graf | Mar 1994 | A |
5305203 | Raab | Apr 1994 | A |
5312405 | Korotko et al. | May 1994 | A |
5413116 | Radke et al. | May 1995 | A |
5514180 | Heggeness et al. | May 1996 | A |
5667506 | Sutterlin | Sep 1997 | A |
5748767 | Raab | May 1998 | A |
5785663 | Sarvazyan | Jul 1998 | A |
6015409 | Jackson | Jan 2000 | A |
6213958 | Winder | Apr 2001 | B1 |
6282437 | Franck et al. | Aug 2001 | B1 |
6302888 | Mellinger et al. | Oct 2001 | B1 |
6364849 | Wilcox | Apr 2002 | B1 |
6385475 | Cinquin et al. | May 2002 | B1 |
6409684 | Wilk | Jun 2002 | B1 |
6443953 | Perra et al. | Sep 2002 | B1 |
6499488 | Hunter et al. | Dec 2002 | B1 |
6565519 | Benesh | May 2003 | B2 |
6585666 | Suh et al. | Jul 2003 | B2 |
6711432 | Krause et al. | Mar 2004 | B1 |
6715213 | Richter | Apr 2004 | B2 |
6716213 | Shitoto | Apr 2004 | B2 |
6746449 | Jones et al. | Jun 2004 | B2 |
6786930 | Biscup | Sep 2004 | B2 |
7066938 | Slivka et al. | Jun 2006 | B2 |
7338526 | Steinberg | Mar 2008 | B2 |
7509183 | Lin et al. | Mar 2009 | B2 |
7534263 | Burdulis, Jr. et al. | May 2009 | B2 |
7542791 | Mire et al. | Jun 2009 | B2 |
7570791 | Frank et al. | Aug 2009 | B2 |
7606613 | Simon et al. | Oct 2009 | B2 |
7611522 | Gorek | Nov 2009 | B2 |
7618451 | Berez et al. | Nov 2009 | B2 |
7634119 | Tsougarakis et al. | Dec 2009 | B2 |
7635367 | Groiso | Dec 2009 | B2 |
7639866 | Pomero et al. | Dec 2009 | B2 |
7660623 | Hunter et al. | Feb 2010 | B2 |
7674293 | Kuiper et al. | Mar 2010 | B2 |
7715602 | Richard | May 2010 | B2 |
7763054 | Clement et al. | Jul 2010 | B2 |
7824413 | Varieur et al. | Nov 2010 | B2 |
7835778 | Foley et al. | Nov 2010 | B2 |
7840253 | Tremblay et al. | Nov 2010 | B2 |
7862593 | Clement et al. | Jan 2011 | B2 |
7918887 | Roche | Apr 2011 | B2 |
7953471 | Clayton et al. | May 2011 | B2 |
7974677 | Mire et al. | Jul 2011 | B2 |
7981158 | Fitz et al. | Jul 2011 | B2 |
7996061 | Mollard et al. | Aug 2011 | B2 |
7996064 | Simon et al. | Aug 2011 | B2 |
8000926 | Roche et al. | Aug 2011 | B2 |
8036441 | Frank et al. | Oct 2011 | B2 |
8038716 | Duggal et al. | Oct 2011 | B2 |
8046050 | Govari et al. | Oct 2011 | B2 |
8066708 | Lang et al. | Nov 2011 | B2 |
8077950 | Tsougarakis et al. | Dec 2011 | B2 |
8083778 | Clement et al. | Dec 2011 | B2 |
8105330 | Fitz et al. | Jan 2012 | B2 |
8142842 | Sugita et al. | Mar 2012 | B2 |
8196825 | Turner et al. | Jun 2012 | B2 |
8211109 | Groiso | Jul 2012 | B2 |
8211153 | Shaolian et al. | Jul 2012 | B2 |
8234097 | Steines et al. | Jul 2012 | B2 |
8241296 | Wasielewski | Aug 2012 | B2 |
8246680 | Betz et al. | Aug 2012 | B2 |
8265790 | Amiot et al. | Sep 2012 | B2 |
8270253 | Roche et al. | Sep 2012 | B1 |
8275594 | Lin et al. | Sep 2012 | B2 |
8308772 | Clement et al. | Nov 2012 | B2 |
8308775 | Clement et al. | Nov 2012 | B2 |
8337501 | Fitz et al. | Dec 2012 | B2 |
8357111 | Caillouette et al. | Jan 2013 | B2 |
8357166 | Aram et al. | Jan 2013 | B2 |
8372075 | Groiso | Feb 2013 | B2 |
8377073 | Wasielewski | Feb 2013 | B2 |
8394142 | Bertagnoli et al. | Mar 2013 | B2 |
8398681 | Augostino et al. | Mar 2013 | B2 |
8400312 | Hotokebuchi et al. | Mar 2013 | B2 |
8414592 | Quimno | Apr 2013 | B2 |
8442621 | Gorek et al. | May 2013 | B2 |
8457930 | Schroeder | Jun 2013 | B2 |
8465527 | Clement | Jun 2013 | B2 |
8494805 | Roche et al. | Jul 2013 | B2 |
8506632 | Ganem et al. | Aug 2013 | B2 |
8532806 | Masson | Sep 2013 | B1 |
8535337 | Chang et al. | Sep 2013 | B2 |
8549888 | Isaacs | Oct 2013 | B2 |
8556983 | Bojarski et al. | Oct 2013 | B2 |
8588892 | Hladio et al. | Nov 2013 | B2 |
8636776 | Rosenberg et al. | Jan 2014 | B2 |
8672948 | Lemaitre | Mar 2014 | B2 |
8685093 | Anderson et al. | Apr 2014 | B2 |
8690888 | Stein et al. | Apr 2014 | B2 |
8705829 | Frank et al. | Apr 2014 | B2 |
8718820 | Amiot et al. | May 2014 | B2 |
8758357 | Frey | Jun 2014 | B2 |
8775133 | Schroeder | Jul 2014 | B2 |
8777877 | Stein et al. | Jul 2014 | B2 |
8784339 | Stein et al. | Jul 2014 | B2 |
8801786 | Bernard et al. | Aug 2014 | B2 |
8814877 | Wasielewski | Aug 2014 | B2 |
8814915 | Hess et al. | Aug 2014 | B2 |
8852237 | Kalfas et al. | Oct 2014 | B2 |
8855389 | Hoffmann et al. | Oct 2014 | B1 |
8864764 | Groiso | Oct 2014 | B2 |
8870889 | Frey | Oct 2014 | B2 |
8900316 | Lenz et al. | Dec 2014 | B2 |
8911448 | Stein | Dec 2014 | B2 |
8926673 | Clement et al. | Jan 2015 | B2 |
8945133 | Stein et al. | Feb 2015 | B2 |
8956416 | McCarthy | Feb 2015 | B2 |
8974467 | Stone | Mar 2015 | B2 |
8983813 | Miles et al. | Mar 2015 | B2 |
8998962 | Birch | Apr 2015 | B2 |
9011448 | Roche et al. | Apr 2015 | B2 |
9034037 | Fiere et al. | May 2015 | B2 |
9039772 | Park et al. | May 2015 | B2 |
9056017 | Kotlus | Jun 2015 | B2 |
9066701 | Finley et al. | Jun 2015 | B1 |
9066734 | Schoenefeld et al. | Jun 2015 | B2 |
9078755 | Mahfouz | Jul 2015 | B2 |
9101492 | Mangione et al. | Aug 2015 | B2 |
9115998 | Proulx et al. | Aug 2015 | B2 |
9119572 | Gorek et al. | Sep 2015 | B2 |
9119671 | Kast | Sep 2015 | B2 |
9125680 | Kostrzewski et al. | Sep 2015 | B2 |
9144440 | Aminian | Sep 2015 | B2 |
9144470 | Proulx et al. | Sep 2015 | B2 |
9168153 | Bettenga | Oct 2015 | B2 |
9173661 | Metzger et al. | Nov 2015 | B2 |
9180015 | Fitz et al. | Nov 2015 | B2 |
9192412 | Meyrat et al. | Nov 2015 | B2 |
9198678 | Frey et al. | Dec 2015 | B2 |
9232955 | Bonin, Jr. et al. | Jan 2016 | B2 |
9233001 | Miles et al. | Jan 2016 | B2 |
9237952 | Kurtz | Jan 2016 | B2 |
9248023 | Ries et al. | Feb 2016 | B2 |
9250620 | Kotlus | Feb 2016 | B2 |
9278010 | Gibson et al. | Mar 2016 | B2 |
9283048 | Kostrzewski et al. | Mar 2016 | B2 |
9289221 | Gelaude et al. | Mar 2016 | B2 |
9289270 | Gielen et al. | Mar 2016 | B2 |
9295482 | Fitz et al. | Mar 2016 | B2 |
9295497 | Schoenefeld et al. | Mar 2016 | B2 |
9295561 | Ball et al. | Mar 2016 | B2 |
9301768 | Buza et al. | Apr 2016 | B2 |
9308050 | Kostrzewski et al. | Apr 2016 | B2 |
9308091 | Lang | Apr 2016 | B2 |
9314275 | Clement et al. | Apr 2016 | B2 |
9314343 | Parisi et al. | Apr 2016 | B2 |
9320547 | Augostino | Apr 2016 | B2 |
9320604 | Miles et al. | Apr 2016 | B2 |
9326780 | Wong et al. | May 2016 | B2 |
9339277 | Jansen et al. | May 2016 | B2 |
9345492 | Stein et al. | May 2016 | B2 |
9358051 | Sournac et al. | Jun 2016 | B2 |
9358130 | Livorsi et al. | Jun 2016 | B2 |
9358136 | Stein et al. | Jun 2016 | B2 |
9364370 | Kuhnel | Jun 2016 | B2 |
9381085 | Axelson, Jr. et al. | Jul 2016 | B2 |
9387015 | Taylor | Jul 2016 | B2 |
9392953 | Gharib | Jul 2016 | B1 |
9393052 | Berg et al. | Jul 2016 | B2 |
9398962 | Steinberg | Jul 2016 | B2 |
9402726 | Linderman et al. | Aug 2016 | B2 |
9408615 | Fitz et al. | Aug 2016 | B2 |
9408642 | Wong et al. | Aug 2016 | B2 |
9408698 | Miles et al. | Aug 2016 | B2 |
9414940 | Stein et al. | Aug 2016 | B2 |
9433443 | Montello et al. | Sep 2016 | B2 |
9439659 | Schoenefeld et al. | Sep 2016 | B2 |
9439767 | Bojarski et al. | Sep 2016 | B2 |
9439781 | Gibson | Sep 2016 | B2 |
9445913 | Donner et al. | Sep 2016 | B2 |
9452022 | McIntosh et al. | Sep 2016 | B2 |
9452023 | Boillot et al. | Sep 2016 | B2 |
9452050 | Miles et al. | Sep 2016 | B2 |
9452064 | Trautwein et al. | Sep 2016 | B2 |
9468436 | Groiso | Oct 2016 | B2 |
9468502 | Wiebe, III et al. | Oct 2016 | B2 |
9491415 | Deitz et al. | Nov 2016 | B2 |
9492183 | Wilkinson et al. | Nov 2016 | B2 |
9495483 | Steines et al. | Nov 2016 | B2 |
9495509 | Amiot et al. | Nov 2016 | B2 |
9498260 | Funk et al. | Nov 2016 | B2 |
9504502 | Kuiper et al. | Nov 2016 | B2 |
9510771 | Finley et al. | Dec 2016 | B1 |
9510864 | Devito | Dec 2016 | B2 |
9517134 | Lang | Dec 2016 | B2 |
9517143 | Prevost et al. | Dec 2016 | B2 |
9526514 | Kelley et al. | Dec 2016 | B2 |
9532730 | Wasielewski | Jan 2017 | B2 |
9539031 | Fauth | Jan 2017 | B2 |
9539116 | Claypool et al. | Jan 2017 | B2 |
9539760 | Stahl et al. | Jan 2017 | B2 |
9547897 | Parent et al. | Jan 2017 | B2 |
9549782 | Park et al. | Jan 2017 | B2 |
9554411 | Hall et al. | Jan 2017 | B1 |
9554910 | Vanasse et al. | Jan 2017 | B2 |
9561115 | Elahinia et al. | Feb 2017 | B2 |
9566075 | Carroll et al. | Feb 2017 | B2 |
9579043 | Chien et al. | Feb 2017 | B2 |
9585597 | McCaulley et al. | Mar 2017 | B2 |
9597096 | Aghazadeh | Mar 2017 | B2 |
9597156 | Amiot et al. | Mar 2017 | B2 |
9603613 | Schoenefeld et al. | Mar 2017 | B2 |
9603623 | Brooks et al. | Mar 2017 | B2 |
9603711 | Bojarski et al. | Mar 2017 | B2 |
9610086 | Park et al. | Apr 2017 | B2 |
9615834 | Agnihotri et al. | Apr 2017 | B2 |
9622712 | Munro et al. | Apr 2017 | B2 |
9629723 | Parisi et al. | Apr 2017 | B2 |
9636181 | Isaacs | May 2017 | B2 |
9642633 | Frey et al. | May 2017 | B2 |
9649170 | Park et al. | May 2017 | B2 |
9655729 | Parisi et al. | May 2017 | B2 |
9662214 | Li et al. | May 2017 | B2 |
9668748 | McKinnon et al. | Jun 2017 | B2 |
9668873 | Winslow et al. | Jun 2017 | B2 |
9675471 | Bojarski et al. | Jun 2017 | B2 |
9693831 | Mosnier et al. | Jul 2017 | B2 |
9715563 | Schroeder | Jul 2017 | B1 |
9757072 | Urbalejo | Sep 2017 | B1 |
9782228 | Mosnier et al. | Oct 2017 | B2 |
9788966 | Steinberg | Oct 2017 | B2 |
9827109 | Steinberg | Nov 2017 | B2 |
9848922 | Tohmeh et al. | Dec 2017 | B2 |
9968408 | Casey et al. | May 2018 | B1 |
9987048 | Mosnier et al. | Jun 2018 | B2 |
9993177 | Chien et al. | Jun 2018 | B2 |
10010426 | Kuiper et al. | Jul 2018 | B2 |
10045824 | Mosnier et al. | Aug 2018 | B2 |
10052135 | Berg et al. | Aug 2018 | B2 |
10064743 | Funk et al. | Sep 2018 | B2 |
10092412 | Drochner et al. | Oct 2018 | B2 |
10098671 | Augostino | Oct 2018 | B2 |
10188480 | Scholl et al. | Jan 2019 | B2 |
10201320 | Saget et al. | Feb 2019 | B2 |
10219865 | Jansen et al. | Mar 2019 | B2 |
10292770 | Ryan et al. | May 2019 | B2 |
10314657 | Mosnier et al. | Jun 2019 | B2 |
10318655 | Mosnier et al. | Jun 2019 | B2 |
10376182 | Herrmann | Aug 2019 | B2 |
10413365 | Mosnier et al. | Sep 2019 | B1 |
10420615 | Mosnier et al. | Sep 2019 | B1 |
10433893 | Scholl et al. | Oct 2019 | B1 |
10433912 | Mosnier et al. | Oct 2019 | B1 |
10433913 | Mosnier et al. | Oct 2019 | B2 |
10441363 | Mosnier et al. | Oct 2019 | B1 |
10456211 | McAfee | Oct 2019 | B2 |
10463433 | Turner et al. | Nov 2019 | B2 |
10517680 | Moctezuma et al. | Dec 2019 | B2 |
10595941 | Herrmann et al. | Mar 2020 | B2 |
10736699 | Ronen et al. | Aug 2020 | B2 |
10777315 | Zehavi et al. | Sep 2020 | B2 |
10874460 | Schmidt et al. | Dec 2020 | B2 |
20020035321 | Bucholz et al. | Mar 2002 | A1 |
20020038118 | Shoham | Mar 2002 | A1 |
20020045812 | Ben-Haim et al. | Apr 2002 | A1 |
20020103432 | Kawchuk | Aug 2002 | A1 |
20030191383 | Ben-Haim et al. | Oct 2003 | A1 |
20030204189 | Cragg | Oct 2003 | A1 |
20040120781 | Luca et al. | Jun 2004 | A1 |
20040143243 | Wahrburg | Jul 2004 | A1 |
20040152972 | Hunter | Aug 2004 | A1 |
20040167637 | Biscup | Aug 2004 | A1 |
20040171924 | Mire et al. | Sep 2004 | A1 |
20040172020 | Beaurain et al. | Sep 2004 | A1 |
20040215190 | Nguyen et al. | Oct 2004 | A1 |
20040243148 | Wasielewski | Dec 2004 | A1 |
20040267279 | Casutt et al. | Dec 2004 | A1 |
20050149050 | Stifter et al. | Jul 2005 | A1 |
20050177239 | Steinberg | Aug 2005 | A1 |
20050182320 | Stifter et al. | Aug 2005 | A1 |
20050182454 | Gharib et al. | Aug 2005 | A1 |
20050203531 | Lakin et al. | Sep 2005 | A1 |
20050203532 | Ferguson | Sep 2005 | A1 |
20050262911 | Dankowicz et al. | Dec 2005 | A1 |
20060015018 | Jutras et al. | Jan 2006 | A1 |
20060015030 | Poulin et al. | Jan 2006 | A1 |
20060036259 | Carl et al. | Feb 2006 | A1 |
20060069324 | Block et al. | Mar 2006 | A1 |
20060074431 | Sutton et al. | Apr 2006 | A1 |
20060136058 | Pietrzak | Jun 2006 | A1 |
20060142657 | Quaid et al. | Jun 2006 | A1 |
20060285991 | McKinley | Dec 2006 | A1 |
20060287627 | Johnson | Dec 2006 | A1 |
20070021682 | Gharib et al. | Jan 2007 | A1 |
20070118243 | Schroeder et al. | May 2007 | A1 |
20070225731 | Couture et al. | Sep 2007 | A1 |
20080058945 | Hajaj et al. | Mar 2008 | A1 |
20080108991 | von Jako | May 2008 | A1 |
20080177203 | von Jako | Jul 2008 | A1 |
20080255575 | Justis et al. | Oct 2008 | A1 |
20080281332 | Taylor | Nov 2008 | A1 |
20090024164 | Neubardt | Jan 2009 | A1 |
20090076615 | Duggal et al. | Mar 2009 | A1 |
20090157083 | Park et al. | Jun 2009 | A1 |
20090194206 | Jeon et al. | Aug 2009 | A1 |
20090204159 | Justis et al. | Aug 2009 | A1 |
20090248080 | Wilcox et al. | Oct 2009 | A1 |
20090249851 | Isaacs | Oct 2009 | A1 |
20090254326 | Isaacs | Oct 2009 | A1 |
20100042157 | Trieu | Feb 2010 | A1 |
20100100011 | Roche | Apr 2010 | A1 |
20100191071 | Anderson et al. | Jul 2010 | A1 |
20100191088 | Anderson et al. | Jul 2010 | A1 |
20100217270 | Polinski et al. | Aug 2010 | A1 |
20100217336 | Crawford et al. | Aug 2010 | A1 |
20110004309 | Holm | Jan 2011 | A9 |
20110071802 | Bojarski et al. | Mar 2011 | A1 |
20110118740 | Rabiner et al. | May 2011 | A1 |
20110172566 | Kawchuk | Jul 2011 | A1 |
20110214279 | Park et al. | Sep 2011 | A1 |
20110224796 | Weiland et al. | Sep 2011 | A1 |
20110257653 | Hughes et al. | Oct 2011 | A1 |
20110257657 | Turner et al. | Oct 2011 | A1 |
20110295159 | Shachar et al. | Dec 2011 | A1 |
20110306873 | Shenai et al. | Dec 2011 | A1 |
20120022357 | Chang et al. | Jan 2012 | A1 |
20120027261 | Frank et al. | Feb 2012 | A1 |
20120035611 | Kave | Feb 2012 | A1 |
20120123301 | Connor et al. | May 2012 | A1 |
20120143090 | Hay et al. | Jun 2012 | A1 |
20120150243 | Crawford et al. | Jun 2012 | A9 |
20120172884 | Zheng et al. | Jul 2012 | A1 |
20120203289 | Beerens et al. | Aug 2012 | A1 |
20130079678 | Stein et al. | Mar 2013 | A1 |
20130079679 | Roche et al. | Mar 2013 | A1 |
20130079790 | Stein et al. | Mar 2013 | A1 |
20130131486 | Copf et al. | May 2013 | A1 |
20130211531 | Steines et al. | Aug 2013 | A1 |
20130245631 | Bettenga | Sep 2013 | A1 |
20130253599 | Gorek et al. | Sep 2013 | A1 |
20130268007 | Rezach et al. | Oct 2013 | A1 |
20130303883 | Zehavi et al. | Nov 2013 | A1 |
20130345718 | Crawford et al. | Dec 2013 | A1 |
20140058407 | Tsekos et al. | Feb 2014 | A1 |
20140100579 | Kelman et al. | Apr 2014 | A1 |
20140135658 | Hladio et al. | May 2014 | A1 |
20140180415 | Koss | Jun 2014 | A1 |
20140194889 | Chang et al. | Jul 2014 | A1 |
20140228670 | Justis et al. | Aug 2014 | A1 |
20140228860 | Steines et al. | Aug 2014 | A1 |
20140244220 | McKinnon et al. | Aug 2014 | A1 |
20140257402 | Barsoum | Sep 2014 | A1 |
20140272881 | Barsoum | Sep 2014 | A1 |
20140277149 | Rooney et al. | Sep 2014 | A1 |
20140296860 | Stein et al. | Oct 2014 | A1 |
20140303672 | Tran et al. | Oct 2014 | A1 |
20140316468 | Keiser et al. | Oct 2014 | A1 |
20150057756 | Lang et al. | Feb 2015 | A1 |
20150066145 | Rogers et al. | Mar 2015 | A1 |
20150080901 | Stein | Mar 2015 | A1 |
20150081029 | Bojarski et al. | Mar 2015 | A1 |
20150088030 | Taylor | Mar 2015 | A1 |
20150100066 | Kostrzewski et al. | Apr 2015 | A1 |
20150100091 | Tohmeh et al. | Apr 2015 | A1 |
20150105782 | D'Lima et al. | Apr 2015 | A1 |
20150127055 | Dvorak et al. | May 2015 | A1 |
20150150646 | Pryor et al. | Jun 2015 | A1 |
20150164657 | Miles et al. | Jun 2015 | A1 |
20150182292 | Hladio et al. | Jul 2015 | A1 |
20150223900 | Wiebe, III et al. | Aug 2015 | A1 |
20150245844 | Kennedy et al. | Sep 2015 | A1 |
20150250597 | Lang et al. | Sep 2015 | A1 |
20150265291 | Wilkinson | Sep 2015 | A1 |
20150305878 | O'Neil et al. | Oct 2015 | A1 |
20150305891 | Bergin et al. | Oct 2015 | A1 |
20150313723 | Jansen et al. | Nov 2015 | A1 |
20150328004 | Mafhouz | Nov 2015 | A1 |
20150366630 | Gorek et al. | Dec 2015 | A1 |
20160000571 | Mahfouz | Jan 2016 | A1 |
20160007983 | Frey et al. | Jan 2016 | A1 |
20160015465 | Steines et al. | Jan 2016 | A1 |
20160022176 | Le Huec et al. | Jan 2016 | A1 |
20160022370 | Pavlovskaia et al. | Jan 2016 | A1 |
20160038161 | Gibson | Feb 2016 | A1 |
20160038238 | Kostrzewski et al. | Feb 2016 | A1 |
20160038242 | Lo Iacono et al. | Feb 2016 | A1 |
20160038293 | Slamin et al. | Feb 2016 | A1 |
20160038307 | Bettenga | Feb 2016 | A1 |
20160045230 | Lowery et al. | Feb 2016 | A1 |
20160045317 | Lang et al. | Feb 2016 | A1 |
20160045326 | Hansen et al. | Feb 2016 | A1 |
20160058320 | Chien et al. | Mar 2016 | A1 |
20160058523 | Chien et al. | Mar 2016 | A1 |
20160074052 | Keppler et al. | Mar 2016 | A1 |
20160074202 | Reed et al. | Mar 2016 | A1 |
20160081754 | Kostrzewski et al. | Mar 2016 | A1 |
20160095710 | Juszczyk et al. | Apr 2016 | A1 |
20160100907 | Gomes | Apr 2016 | A1 |
20160106483 | Mayer et al. | Apr 2016 | A1 |
20160128847 | Kurtaliaj et al. | May 2016 | A1 |
20160143744 | Bojarski et al. | May 2016 | A1 |
20160157751 | Mahfouz | Jun 2016 | A1 |
20160199101 | Sharifi-Mehr et al. | Jul 2016 | A1 |
20160228192 | Jansen et al. | Aug 2016 | A1 |
20160235480 | Scholl et al. | Aug 2016 | A1 |
20160235493 | LeBoeuf, II et al. | Aug 2016 | A1 |
20160242819 | Simpson et al. | Aug 2016 | A1 |
20160242857 | Scholl | Aug 2016 | A1 |
20160242934 | van der Walt et al. | Aug 2016 | A1 |
20160256279 | Sanders et al. | Sep 2016 | A1 |
20160256285 | Jansen | Sep 2016 | A1 |
20160262800 | Scholl et al. | Sep 2016 | A1 |
20160262895 | Shea et al. | Sep 2016 | A1 |
20160270802 | Fang et al. | Sep 2016 | A1 |
20160270931 | Trieu | Sep 2016 | A1 |
20160274571 | Lavallee et al. | Sep 2016 | A1 |
20160283676 | Lyon et al. | Sep 2016 | A1 |
20160287395 | Khalili et al. | Oct 2016 | A1 |
20160296285 | Chaoui et al. | Oct 2016 | A1 |
20160310221 | Bar et al. | Oct 2016 | A1 |
20160331417 | Trautwein et al. | Nov 2016 | A1 |
20160354009 | Schroeder | Dec 2016 | A1 |
20160354161 | Deitz | Dec 2016 | A1 |
20160360997 | Yadav et al. | Dec 2016 | A1 |
20170000568 | O'Neil et al. | Jan 2017 | A1 |
20170007145 | Gharib et al. | Jan 2017 | A1 |
20170007328 | Cattin et al. | Jan 2017 | A1 |
20170007408 | Fitz et al. | Jan 2017 | A1 |
20170027590 | Amiot et al. | Feb 2017 | A1 |
20170027617 | Strnad | Feb 2017 | A1 |
20170035580 | Murphy | Feb 2017 | A1 |
20170056179 | Lorio | Mar 2017 | A1 |
20170056196 | Kuiper et al. | Mar 2017 | A1 |
20170071503 | Wasielewski | Mar 2017 | A1 |
20170119316 | Herrmann et al. | May 2017 | A1 |
20170119472 | Herrmann et al. | May 2017 | A1 |
20170132389 | McCaulley et al. | May 2017 | A1 |
20170135706 | Frey et al. | May 2017 | A1 |
20170135707 | Frey et al. | May 2017 | A9 |
20170135770 | Scholl et al. | May 2017 | A1 |
20170143426 | Isaacs et al. | May 2017 | A1 |
20170143494 | Mahfouz | May 2017 | A1 |
20170143502 | Yadin et al. | May 2017 | A1 |
20170156798 | Wasielewski | Jun 2017 | A1 |
20170189121 | Frasier et al. | Jul 2017 | A1 |
20170231709 | Gupta et al. | Aug 2017 | A1 |
20170252107 | Turner et al. | Sep 2017 | A1 |
20170273718 | Metzger et al. | Sep 2017 | A1 |
20170323037 | Schroeder | Nov 2017 | A1 |
20170360493 | Zucker et al. | Dec 2017 | A1 |
20180092699 | Finley | Apr 2018 | A1 |
20180178148 | Mazor et al. | Jun 2018 | A1 |
20180256067 | Chien et al. | Sep 2018 | A1 |
20180289396 | McGahan et al. | Oct 2018 | A1 |
20180295584 | Gliner et al. | Oct 2018 | A1 |
20180301213 | Zehavi et al. | Oct 2018 | A1 |
20180303552 | Ryan | Oct 2018 | A1 |
20180310993 | Hobeika | Nov 2018 | A1 |
20180349519 | Schroeder | Dec 2018 | A1 |
20190015136 | Kraemer | Jan 2019 | A1 |
20190046269 | Hedblom et al. | Feb 2019 | A1 |
20190046287 | Fallin et al. | Feb 2019 | A1 |
20190059951 | Barrus | Feb 2019 | A1 |
20190060086 | Krause et al. | Feb 2019 | A1 |
20190083144 | Sharifi-Mehr et al. | Mar 2019 | A1 |
20190103190 | Schmidt et al. | Apr 2019 | A1 |
20190110819 | Triplett et al. | Apr 2019 | A1 |
20190117278 | Chin | Apr 2019 | A1 |
20190122364 | Zhang et al. | Apr 2019 | A1 |
20190142599 | Thibodeau | May 2019 | A1 |
20190167314 | Mosnier et al. | Jun 2019 | A1 |
20190167435 | Cordonnier | Jun 2019 | A1 |
20190201013 | Siccardi et al. | Jul 2019 | A1 |
20190201155 | Gupta et al. | Jul 2019 | A1 |
20190209080 | Gullotti et al. | Jul 2019 | A1 |
20190209212 | Scholl et al. | Jul 2019 | A1 |
20190223916 | Barrus et al. | Jul 2019 | A1 |
20190231443 | McGinley et al. | Aug 2019 | A1 |
20190231557 | Sutterlin, III et al. | Aug 2019 | A1 |
20190239935 | Willis et al. | Aug 2019 | A1 |
20190247100 | Mundis, Jr. et al. | Aug 2019 | A1 |
20190254769 | Scholl et al. | Aug 2019 | A1 |
20190262015 | Siccardi et al. | Aug 2019 | A1 |
20190269463 | Mosnier et al. | Sep 2019 | A1 |
20190343587 | Mosnier et al. | Nov 2019 | A1 |
20190362028 | Mosnier et al. | Nov 2019 | A1 |
20190380782 | McAfee et al. | Dec 2019 | A1 |
20200038109 | Steinberg | Feb 2020 | A1 |
20200060768 | Mosnier et al. | Feb 2020 | A1 |
20200121394 | Mosnier et al. | Apr 2020 | A1 |
20200297424 | Helm et al. | Sep 2020 | A1 |
20200297425 | Helm et al. | Sep 2020 | A1 |
20200315708 | Mosnier et al. | Oct 2020 | A1 |
20200345420 | Hobeika et al. | Nov 2020 | A1 |
20210059822 | Casey et al. | Mar 2021 | A1 |
20210145518 | Mosnier et al. | May 2021 | A1 |
20210244447 | Schroeder | Aug 2021 | A1 |
20220160428 | Murray | May 2022 | A1 |
Number | Date | Country |
---|---|---|
2017064719 | Apr 2017 | WO |
2018131045 | Jul 2018 | WO |
2019043426 | Mar 2019 | WO |
2019148154 | Aug 2019 | WO |
2019217824 | Nov 2019 | WO |
2022269345 | Dec 2022 | WO |
Entry |
---|
International Search Report in Application No. PCT/IB2022/000331 mailed Nov. 25, 2022. |
Written Opinion in Application No. PCT/IB2022/000331 mailed Nov. 25, 2022. |
“Predicting 3D Thoracic Kyphosis Using Traditional 2D Radiographic Measurements in Adolecent Idiopathic Scoliosis,” by Kevin Parvaresh, MD, Spine Deformity 5 (2017) 159-165. |
“Compensatory Spinopelvic Balance Over the Hip Axis and Better Reliability in Measuring Lordosis to the Pelvic Radius on Standing Lateral Radiographs of Adult Volunteers and Patients,” Roger P. Jackson MD, et al., Spine vol. 23, No. 16, pp. 1750-1767, copyright 1998, Lippincott Williams & Wilkins. |
“Postoperative Changes in Spinal Rod Contour in Adolescent Idiopathic Scoliosis, An in Vivo Deformtion Study,” by Krishna R. Cidambi, MD et al., Spine vol. 37, No. 18, pp. 1566-1572, copyright 2012, Lippincott Williams & Wilkins. |
Renaud Lafage, et al., Surgical Planning for Adult Spinal Deformity: Anticipated Sagittal Alignment Corrections Accordings to the Surgical Level, Global Spine Journal, sagepub.com/journals-permissions, DOI: 10.177/2192568220988504 journals.sagepub.com/home/gsj © The Authors(s) 2021, pp. 1-9. |
Number | Date | Country | |
---|---|---|---|
20220409279 A1 | Dec 2022 | US |